Gyeonggi-do, South Korea

Sin Cheol Kang




Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sin Cheol Kang: Innovator in Neurological Treatments

Introduction

Sin Cheol Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurological diseases. With a total of two patents to his name, Kang's work is recognized for its potential impact on medical science.

Latest Patents

Kang's latest patents include a novel quinazoline-2,4-dione derivative and medical compositions for the prophylaxis and treatment of cranial nerve disease. The invention relates to a compound of formula (I), which is a pharmaceutically acceptable salt and serves as an active ingredient in pharmaceutical compositions aimed at preventing or treating neurological brain diseases. This innovative approach highlights the importance of his research in addressing critical health issues.

Career Highlights

Throughout his career, Sin Cheol Kang has worked with reputable companies such as Shin Poong Pharmaceutical Co., Ltd. and Shin Poong Pharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Kang has collaborated with notable coworkers, including Eun Bang Lee and Won Seok Kim. These partnerships have likely enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Sin Cheol Kang's contributions to the field of pharmaceuticals, particularly in neurological treatments, demonstrate his commitment to innovation and improving healthcare outcomes. His patents reflect a significant advancement in medical science, showcasing the potential for new therapies in treating complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…